Procter & Gamble Health (PGHL) Share Price Rises 7.11% Today on PGHL Update

PGHL Share Price moved higher today, with Procter & Gamble Health trading at Rs 5,790, up 7.11%, and a market capitalisation of Rs 8,972.96 crore as of 29 September 2026 at 1:30:18 PM IST. The latest Univest data confirms a clear share price rise, but no company-specific catalyst is established. PGHL Share Price therefore stands out as a price action event first, with fundamentals and sector positioning helping to frame the move. Univest data also shows that the stock’s valuation and profitability metrics remain important context for investors tracking PGHL Share Price Today, especially in Healthcare and Pharmaceuticals & Drugs. For readers scanning PGHL Stock News and PGHL Stock Analysis, the key question is not only what happened, but how the current numbers compare with sector benchmarks and peers.

PGHL Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 5,790
Previous Close	Rs 5,405.6
Today's Move	Rs 384.4 (+7.11%)
Open	Rs 5,463
High	Rs 5,790
Low	Rs 5,440.05
Market Capitalisation	Rs 8,972.96 crore
Market Cap Category	Mid Cap

Procter & Gamble Health Ltd. (PGHL) rose to Rs 5,790 from the previous close of Rs 5,405.6, a move of Rs 384.4 or 7.11%. The stock opened at Rs 5,463, reached a high of Rs 5,790, recorded a low of Rs 5,440.05.

The PGHL Share Price is trading at Rs 5,790, up Rs 384.40, or 7.11%, from the previous close of Rs 5,405.60. The stock opened at Rs 5,463, touched a high of Rs 5,790 and a low of Rs 5,440.05, which keeps the move firmly within today’s trading range. PGHL Share Price Today reflects a decisive upward re-pricing in the current market session, and the latest Univest figures confirm that the top price point so far matches the day’s high. PGHL Share Price Live therefore shows a strong intraday advance rather than a drifting move. With market capitalisation at Rs 8,972.96 crore, PGHL Share Price remains a closely watched name in Stock Market Today coverage and in Stocks in News tracking. The next layer of analysis is the company’s financial profile, which gives the PGHL Share Price rise more context.

Procter & Gamble Health Ltd. (PGHL) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 8,972.96 crore
P/E Ratio	25.14x
P/B Ratio	14.58x
ROE	62.18%
ROCE	84.86%
EPS	Rs 215
Book Value Per Share	Rs 370.86
Dividend Yield	3.79%

Procter & Gamble Health Ltd. (PGHL) fundamental metrics show P/E 25.14x, P/B 14.58x, ROE 62.18%, ROCE 84.86%. Read together, these ratios describe the company's position rather than a recommendation.

Procter & Gamble Health Ltd. has a market capitalisation of Rs 8,972.96 crore and falls in the Mid Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 25.14x, P/B at 14.58x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 62.18% and ROCE of 84.86%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 215, book value per share of Rs 370.86, dividend yield of 3.79%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 32.59x, median ROE of 11.7%, median ROCE of 13.61%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	25.14x
Benchmark Median P/E	32.59x
Benchmark Average P/E	49x
Benchmark P/E Range	3.46x to 707.31x
Company P/B Ratio	14.58x
Benchmark Median P/B	2.88x
Company ROE	62.18%
Benchmark Median ROE	11.7%
Company ROCE	84.86%
Benchmark Median ROCE	13.61%
Company Market Capitalisation	Rs 8,972.96 crore
Benchmark Median Market Cap	Rs 783.26 crore

Procter & Gamble Health Ltd. (PGHL) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.

Procter & Gamble Health Ltd. (PGHL) has a P/E ratio of 25.14x, which is below the benchmark median of 32.59x, a difference of -22.86%. The P/E comparison frames valuation; it is not a signal to buy or sell.

Procter & Gamble Health Ltd. (PGHL) has a ROE of 62.18%, which is above the benchmark median of 11.7%, a difference of +431.45%. Procter & Gamble Health Ltd. (PGHL) has a ROCE of 84.86%, which is above the benchmark median of 13.61%, a difference of +523.51%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Sun Pharmaceutical Industries Ltd.	SUNPHARMA	4,44,716.74	36.5	5.1	14.85	19.11
Divi's Laboratories Ltd.	DIVISLAB	2,55,115.31	86.51	14.33	16.19	21.51
Torrent Pharmaceuticals Ltd.	TORNTPHARM	1,89,613.38	84.92	20.64	26.76	19.27
Zydus Lifesciences Ltd.	ZYDUSLIFE	1,19,899.96	26.79	4.48	19.69	21.39
Cipla Ltd.	CIPLA	1,12,875.68	33.29	3.19	11.83	16

Procter & Gamble Health Ltd. (PGHL) has a P/E ratio of 25.14x compared with the displayed peer median of 36.5x. Peer multiples give relative context only, not a buy or sell view. Its ROE of 62.18% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 84.86% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Procter & Gamble Health Ltd. (PGHL) has a market capitalisation of Rs 8,972.96 crore. All 5 peers shown have a larger market capitalisation.

Why Investors Are Watching PGHL

• PGHL Share Price is trading 7.11% higher today, with the day’s high matching the current price.
• PGHL Share Price Today is supported by an EPS of Rs 215 and book value of Rs 370.86 per share.
• PGHL Fundamental Analysis shows ROE of 62.18% and ROCE of 84.86%, both well above industry norms.
• PGHL Share Price sits below the industry median P/E and above the industry median P/B, making valuation a live comparison point.
• PGHL Stock News stays relevant because the move is taking place inside a Healthcare peer set with varied valuation and return profiles.

About PGHL

Procter & Gamble Health Ltd., tracked on NSE and BSE as PGHL, operates in Healthcare within the Pharmaceuticals & Drugs industry. PGHL Share Price is tied to a business that sits inside a sector where returns, valuation and market capitalisation vary sharply across listed companies. The company’s profile in Univest data highlights market capitalisation, earnings per share, book value and dividend yield as the most visible financial markers for investors following PGHL Share Price Today.

PGHL Share Price is therefore best understood through company overview, company financials and stock performance context rather than broad market commentary. For readers scanning PGHL Company News or PGHL Earnings, the main factual anchors are its P/E of 25.14, P/B of 14.58, ROE of 62.18%, ROCE of 84.86%, EPS of Rs 215 and dividend yield of 3.79%. These numbers frame the company’s position inside Healthcare and support a more informed reading of PGHL Stock Analysis.

Frequently Asked Questions

Why is PGHL Share Price rising today?

Ans. PGHL Share Price is rising today on a verified intraday price move of 7.11% to Rs 5,790. According to Univest data, no company-specific catalyst is established, so the event is best read as a price action move.

What is PGHL Share Price Today?

Ans. PGHL Share Price Today is Rs 5,790, which is Rs 384.40 above the previous close of Rs 5,405.60. The stock also touched the day’s high of Rs 5,790 during the session.

How much did PGHL Share Price rise?

Ans. PGHL Share Price rose by Rs 384.40, or 7.11%, in the current session. That makes it one of the sharper intraday moves among Healthcare names tracked in Univest data today.

What is the market capitalisation of PGHL?

Ans. PGHL has a market capitalisation of Rs 8,972.96 crore. That places PGHL Share Price in a company-size bracket that is far below the industry average market capitalisation in the same benchmark set.

Is PGHL expensive on valuation metrics?

Ans. PGHL Share Price carries a P/E of 25.14 and a P/B of 14.58. Against the same-industry median P/E of 32.59, the earnings multiple is lower, while the book multiple is much higher.

How do PGHL ROE and ROCE compare with the industry?

Ans. PGHL Share Price is backed by ROE of 62.18% and ROCE of 84.86%. Both are far above the same-industry medians of 11.7% and 13.61%, showing a strong return profile on exact numbers.

What is the EPS of PGHL Share Price?

Ans. PGHL reports EPS of Rs 215. For PGHL Share Price, that means each share is backed by a clearly stated earnings figure, which is useful for comparing valuation, profitability and peer positioning.

Should investors track PGHL Share Price on Univest?

Ans. Yes, PGHL Share Price can be tracked on Univest for live price updates, market capitalisation, valuation ratios, 52-week levels and sector context. That helps readers follow the stock without relying only on intraday price movement.

Track PGHL Share Price on Univest

Use Procter & Gamble Health Ltd. (PGHL) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

Investors tracking PGHL Share Price Today can use Univest to follow the live share price, key valuation ratios, market capitalisation, 52-week levels and company insights in one place. PGHL Share Price updates on Univest also help readers compare the stock with sector benchmarks and listed peers without losing the core price action detail.